Discontinuation report DDAVP RHINYLE
Report ID | 132472 |
Drug Identification Number | 00402516 |
Brand name | DDAVP RHINYLE |
Common or Proper name | Desmopressin acetate nasal solution |
Company Name | FERRING INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DESMOPRESSIN ACETATE |
Strength(s) | 0.1MG |
Dosage form(s) | SOLUTION |
Route of administration | NASAL NASAL |
Packaging size | 2.5 mL |
ATC code | H01BA |
ATC description | POSTERIOR PITUITARY LOBE HORMONES |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | 2021-01-29 |
Actual discontinuation date | 2021-01-29 |
Remaining supply date | 2021-01-29 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Final units were sold in the week of Jan. 25th, 2021 |
Company comments | Supplier of Nasal dropper is no longer able to supply the "Sanodropper". Ferring has no viable alternative. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-03-02 | French | Compare |
v3 | 2021-03-02 | English | Compare |
v2 | 2021-01-26 | French | Compare |
v1 | 2021-01-26 | English | Compare |
Showing 1 to 4 of 4